Share This Article:

Detection of Epstein-Barr Virus in Nasopharyngeal Carcinoma in Sudanese by in Situ Hybridization

Abstract Full-Text HTML Download Download as PDF (Size:316KB) PP. 517-522
DOI: 10.4236/jct.2014.56059    4,376 Downloads   5,741 Views   Citations

ABSTRACT

Objectives: The aim of this study is to detect Epstein-Barr virus (EBV) in nasopharyngeal carcinoma (NPC) biopsies of Sudanese patients using EBV-encoded RNA (EBER) in Situ hybridization (EBER-ISH). Study Design: This is a descriptive cross-sectional study conducted at the National Center for ENT diseases and Head and Neck Surgery and the Institute of Endemic Diseases, University of Khartoum, Khartoum City, Sudan. Subjects and Methods: Biopsies from 43 patients with nasopharyngeal carcinoma were examined for the presence of Epstein-Barr virus using EBER-ISH. Ten normal samples were used to assess the presence of the virus in non cancer tissues. Results: Fifty three samples were examined for the presence of the virus by EBER-ISH, 43 biopsies were NPC and ten were normal. Histologically the cases were, 20 (46.5%), 20 (46.5%) and 3 (7%) of the biopsies were classified as WHO types II, III and mixed type II and III, respectively; there were no cases of type I NPC. All nasopharyngeal carcinoma biopsies (100%) were positive for EBER1 in almost all carcinoma cells with focal and intense dark-blue staining limited to the nucleus; no hybridization was observed in the cytoplasm. No hybridization was observed in all ten non cancer tissues. Conclusion: All NPC cells are clearly EBV-infected. The virus is located in the nucleus of the tumour cells. The presence of Epstein-Barr virus in normal nasopharyngeal epithelia is not a common event. Objectives: The aim of this study is to detect Epstein-Barr virus (EBV) in nasopharyngeal carcinoma (NPC) biopsies of Sudanese patients using EBV-encoded RNA (EBER) in Situ hybridization (EBER-ISH). Study Design: This is a descriptive cross-sectional study conducted at the National Center for ENT diseases and Head and Neck Surgery and the Institute of Endemic Diseases, University of Khartoum, Khartoum City, Sudan. Subjects and Methods: Biopsies from 43 patients with nasopharyngeal carcinoma were examined for the presence of Epstein-Barr virus using EBER-ISH. Ten normal samples were used to assess the presence of the virus in non cancer tissues. Results: Fifty three samples were examined for the presence of the virus by EBER-ISH, 43 biopsies were NPC and ten were normal. Histologically the cases were, 20 (46.5%), 20 (46.5%) and 3 (7%) of the biopsies were classified as WHO types II, III and mixed type II and III, respectively; there were no cases of type I NPC. All nasopharyngeal carcinoma biopsies (100%) were positive for EBER1 in almost all carcinoma cells with focal and intense dark-blue staining limited to the nucleus; no hybridization was observed in the cytoplasm. No hybridization was observed in all ten non cancer tissues. Conclusion: All NPC cells are clearly EBV-infected. The virus is located in the nucleus of the tumour cells. The presence of Epstein-Barr virus in normal nasopharyngeal epithelia is not a common event.

KEYWORDS

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Adam, A. , Abdullah, N. , El Hassan, L. , Elamin, E. , Ibrahim, M. and El Hassan, A. (2014) Detection of Epstein-Barr Virus in Nasopharyngeal Carcinoma in Sudanese by in Situ Hybridization. Journal of Cancer Therapy, 5, 517-522. doi: 10.4236/jct.2014.56059.

References

[1] Yu, M.C. and Yuan, J. (2006) Nasopharyngeal Cancer. In: Schottenfeld, D. and Fraumeni, J.F., Eds., Cancer Epidemiology and Prevention, Oxford University Press, New York, 620-626.
http://dx.doi.org/10.1093/acprof:oso/9780195149616.003.0031
[2] Abdullah, N.E., Adam, A.A.M., Khalifa, E.H., El Hassan, L.A.M., Elamin, E.M., Hamad, K.M. et al. (2011) Nasopharyngeal Cancer in Sudan: Epidemiology, Clinical and Histological Characteristics. Clinical Medicine Insights: Ear, Nose and Throat, 4, 5-11. http://dx.doi.org/10.4137/CMENT.S5825
[3] Hidayatalla, A.M.O., Malik, A.E., El Hadi, A.A., Osman, A.A and Hutt, M.S. (1983) Studies on Nasopharyngeal Carcinoma in the Sudan—I Epidemiology and Aetiology. European Journal of Cancer and Clinical Oncology, 19, 705-710. http://dx.doi.org/10.1016/0277-5379(83)90001-9
[4] Wei, W.I. and Sham, J.S. (2005) Nasopharyngeal Carcinoma. Lancet, 365, 2041-2054.
http://dx.doi.org/10.1016/S0140-6736(05)66698-6
[5] Adam, A.A.M., Abdullah, N.E., Khalifa, E.H., El Hassan, L.A.M., Elamin, E.M., Hamad, K.M., et al. (2011) Pathology of Nasopharyngeal Carcinoma in Sudanese Patients and Its Association with Epstein-Barr Virus: A Report from a Single Center in Khartoum. Advances in Tumor Virology, 2, 1-6.
http://dx.doi.org/10.4137/ATV.S5817
[6] Kieff, E. (1995) Epstein-Barr Virus—Increasing Evidence of a Link to Carcinoma. The New England Journal of Medicine, 333, 724-726. http://dx.doi.org/10.1056/NEJM199509143331110
[7] Neel, H.B. 3rd, Pearson, G.R. and Taylor, W. (1984) Antibodies to Epstein-Barr Virus in Patients with Nasopharyngeal Carcinoma and in Comparison Groups. Annals of Otology, Rhinology, and Laryngology, 93, 477-482.
[8] Cohen, J. (2002) Epstein-Barr Virus Infection. The New England Journal of Medicine, 343, 481-492. http://dx.doi.org/10.1056/NEJM200008173430707
[9] Pagano, J.S., Blaser, M., Buendia, M.A., Damania, B., Khalili, K., Raab-Traub, N. and Roizman, B. (2004) Infectious Agents and Cancer: Criteria for a Causal Relation. Seminars in Cancer Biology, 14, 453-471. http://dx.doi.org/10.1016/j.semcancer.2004.06.009
[10] Lanier, A.P., Bornkamm, G.W., Henle, W., Henle, G., Bender, T.R., Talbot, M.L., et al. (1981) Association of EpsteinBarr virus with Nasopharyngeal Carcinoma in Alaskan Native Patients: Serum Antibodies and Tissue EBNA and DNA. International Journal of Cancer, 28, 301-305.
http://dx.doi.org/10.1002/ijc.2910280308
[11] Akao, I., Sato, Y., Mukai, K., Uhara, H., Furuya, S., Hoshikawa, T., et al. (1991) Detection of Epstein-Barr Virus DNA in Formalin-Fixed Paraffin-Embedded Tissue of Nasopharyngeal Carcinoma Using Polymerase Chain Reaction and in Situ Hybridization. Laryngoscope, 101, 279-283.
http://dx.doi.org/10.1288/00005537-199103000-00010
[12] Niedobitek, G., Fahraeus, R,. Herbst, H., Latza, U., Ferszt, A., Klein, G., et al. (1992) The Epstein-Barr Virus Encoded Membrane Protein (LMP) Induces Phenotypic Changes in Epithelial Cells. Virchows Archiv B, 62, 55-59. http://dx.doi.org/10.1007/BF02899665
[13] Weiss, L.M., Movahed, L.A., Butler, A.E., Swanson, S.A., Frierson, H.F.J., Cooper, P.H., et al. (1989) Analysis of Lymphoepithelioma and Lymphoepithelioma-Like Carcinomas for Epstein-Barr Viral Genomes by in Situ Hybridization. American Journal of Surgical Pathology, 13, 625-631.
http://dx.doi.org/10.1097/00000478-198908000-00001
[14] Howe, J.G. and Shu, M.D. (1988) Isolation and Characterization of the Genes for Two Small RNAs of Herpesvirus papio and Their Comparison with Epstein-Barr Virus-Encoded EBER RNAs. Journal of Virology, 62, 2790-2798.
[15] Tsai, S.T., Jin, Y.T., Mann, R.B. and Ambinder, R.F. (1998) Epstein-Barr Virus Detection in Nasopharyngeal Tissues of Patients with Suspected Nasopharyngeal Carcinoma. Cancer, 82, 1449-1453.
[16] Nakado, K., Mochiki, M., Nibu, K., Sugasaywa, M. and Uozaki, H. (2006) Analysis of Prognostic Factors of Nasopharyngeal Carcinoma: Impact of in Situ Hybridization for Epstein-Barr Virus Encoded Small RNA 1. Otolaryngology—Head and Neck Surgery, 134, 639-645.
http://dx.doi.org/10.1016/j.otohns.2005.11.022
[17] Kengjian, K., Haiyun, W., Zichen, S., Liping, D., Dabo, L. and Jin, Y. (2014) Epstein-Barr Virus-Encoded RNAs as a Survival Predictor in Nasopharyngeal Carcinoma. Chinese Medical Journal, 2, 294-299.
[18] zur Hausen, H., Schulte-Holthausen, H., Klein, G., Henle, W., Henle, G., Clifford, P., et al. (1970) EBV DNA in Biopsies of Burkitt’s Tumours and Anaplastic Carcinomas of the Nasopharynx. Nature, 228, 1056-1058. http://dx.doi.org/10.1038/2281056a0
[19] Chang, K.L., Chen, Y.Y., Shibata, D. and Weiss, L.M. (1992) Description of an in Situ Hybridization Methodology for Detection of Epstein-Barr Virus RNA in Paraffin-Embedded Tissues, with a Survey of Normal and Neoplastic Tissues. Diagnostic Molecular Pathology, 1, 246-255.
http://dx.doi.org/10.1097/00019606-199203000-00037
[20] Chan, A.T.C., Teo, P.M.L and Johnson, P.J. (2002) Nasopharyngeal Carcinoma. Annals of Oncology, 13, 1007-1015. http://dx.doi.org/10.1093/annonc/mdf179
[21] Collins, S.L. (1996) Squamous Cell Carcinoma of the Oral Cavity and Oropharynx. In: Ballenger, J. and Snow, J., Eds., Otorhinolaryngology: Head and Neck Surgery, Media, Williams & Wilkins, 249-368.
[22] Inoue, H., Sato, Y., Tsuchiya, B., Nagai, H., Takahashi, H. and Kameya, T. (2002) Expression of Epstein-Barr Virus Encoded Small Nuclear RNA1 in Japanese Nasopharyngeal Carcinomas. Acta Oto-Laryngologica, 547, 113-117. http://dx.doi.org/10.1080/000164802760057725
[23] Pathmanathan, R., Prasad, U., Chandrika, G., Sadler, R., Flynn, K. and Traub, R.N. (1995) Undifferentiated, Nonkeratinizing, and Squamous Cell Carcinoma of the Nasopharynx: Variants of Epstein Barr Virus-Infected Neoplasia. American Journal of Pathology, 146, 1355-1367.
[24] Gabusi, E., Lattes, C., Fiorentino, M., D’Errico, A. and Grigioni, W.F. (2001) Expression of Epstein-Barr Virus-Encoded RNA and Biological Markers in Italian Nasopharyngeal Carcinomas. Journal of Experimental & Clinical Cancer Research, 20, 371-376.
[25] Plaza, G., Manzanal, A.I., Fogué, L., Santón, A., Martínez-Montero, J.C. and Bellas, C. (2002) Association of Epstein-Barr Virus and Nasopharyngeal Carcinoma in Caucasian Patients. Annals of Otology, Rhinology, and Laryngology, 111, 210-216.
[26] Lin, Z., Khong, B., Kwok, S., Cao, H., West, R.B., Le, Q. and Kong C. (2014) Human Papiloma Virus 16 Detected in Nasopharyngeal Carcinomas in Caucasian American But Not in Endemic Southern Chinese Patients. Head & Neck, 36, 709-714. http://dx.doi.org/10.1002/hed.23362
[27] Laantri, N., Attaleb, M., Kandil, M., Naji, F., Mouttaki, T., Dardari, R., et al. (20011) Human Papillomavirus Detection in Moroccan Patients with Nasopharyngeal Carcinoma. Infect Agent Cancer, 6, 3.
[28] Mirzamani, N., Salehian, P., Farhadi, M. and Tehran, E.A. (2006) Detection of EBV and HPV in Nasopharyngeal Carcinoma by in Situ Hybridization. Experimental and Molecular Pathology, 81, 231-234 http://dx.doi.org/10.1016/j.yexmp.2006.04.006
[29] Ertan, Y., Hekimgil, M., Karaarslan, S. and Soydan, S. (2008) Expression of Epstein-Barr-Virus-Encoded Small Nuclear RNA in Nasopharyngeal Carcinomas of Aegean Turkish Patients. Virchows Arch, 452, 411-414. http://dx.doi.org/10.1007/s00428-008-0589-6
[30] Sam, C.K., Boorks, L.A., Niedoitek, G., Young, L.S., Prasad, U. and Riskinson, A.B. (1993) Analysis of Epstein-Barr Virus Infection in Nasopharyngeal Carcinoma from a Group at High Risk of Nasopharyngeal Carcinoma. International Journal of Cancer, 53, 957-962.
http://dx.doi.org/10.1002/ijc.2910530616
[31] Dickens, P., Srivastava, G., Loke, S.L., Chan, C.W. and Liu, Y.T. (1992) Epstein-Barr Virus DNA in Nasopharyngeal Carcinomas from Chinese Patients in Hong Kong. Journal of Clinical Pathology, 45, 396-397. http://dx.doi.org/10.1136/jcp.45.5.396

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.